Clinical trialNCT07154823RecruitingObservational

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

SponsorTempus AIEnrollment550Acute Myeloid Leukaemia (AML)Follicular Lymphoma ( FL)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies. It will collect rich molecular (multi-omic) and clinical data from patient cohorts through serial blood draws and the acquisition of leftover tissue and/or bone marrow aspirates during their routine therapy and disease monitoring. The primary goal is to understand the association between biomarkers and real-world clinical outcomes in these patient populations.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael Thompson, MD, PhD, FASCO
Tempus AI
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Iowa Hospital and Clinics
Iowa City, Iowa, United States
Hira Shaikh, MD
Recruiting
the Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
Shreya Desai
Recruiting
Washington University in St. Louis
St Louis, Missouri, United States
David Russler-Germain, MD
Recruiting
Cancer Care Specialists of Reno
Reno, Nevada, United States
Juan Adolfo Cattoni III
Recruiting
University of Cincinnati
Cincinnati, Ohio, United States
Emily Curran
Recruiting
Ohiohealth Research Institute
Columbus, Ohio, United States
Bassem William
Recruiting
Taylor Cancer Research Center
Maumee, Ohio, United States
John Nemunaitis
Recruiting
Cancer Care Associates of York
York, Pennsylvania, United States
Jackson Gao
Recruiting
Avera Cancer Institue
Sioux Falls, South Dakota, United States
Waqas Jehangir
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Jan 2026
Primary completion: 30 Nov 2034
Completion: 30 Nov 2035
Last update posted: 21 Jul 2026
Registered enrollment: 550
Registry id: NCT07154823

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.